FDA clears Olympus duodenoscope with design modifications
Advertisement
The U.S. Food and Drug Administration cleared Japan's Olympus Corp's duodenoscope with changes to the device's design and labeling intended to help reduce the risk of bacterial infections.
Olympus will voluntarily recall its original model being used in health care facilities to fix them as quickly as possible, the regulator said.
The FDA in August asked health care facilities using these and other reusable medical devices to meticulously follow the cleaning instructions to avoid the spread of superbugs.
Olympus is the biggest maker of the device.
Olympus will voluntarily recall its original model being used in health care facilities to fix them as quickly as possible, the regulator said.
The FDA in August asked health care facilities using these and other reusable medical devices to meticulously follow the cleaning instructions to avoid the spread of superbugs.
Olympus is the biggest maker of the device.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.